Surgical endarterectomy is the therapy of choice for atherosclerotic common femoral artery (CFA) obstruction. Recently, some large single-centre series have shown encouraging results for the percutaneous treatment of CFA obstructions. The purpose of this study was to evaluate the safety, feasibility, and one-year efficacy of the endovascular treatment of CFA obstructions with combined use of directional atherectomy (DA) and a paclitaxel-coated balloon (DCB).
Combined use of directional atherectomy and drug-coated balloon for the endovascular treatment of common femoral artery disease: immediate and one-year outcomes / Cioppa, A., Stabile, E., Salemme, L., Popusoi, G., Pucciarelli, A., Iacovelli, F., Arcari, A., Coscioni, E., Trimarco, B., Esposito, G., Tesorio, T.. - In: EUROINTERVENTION. - ISSN 1774-024X. - 12:14(2017), pp. 1789-1794-1794. [10.4244/EIJ-D-15-00187]
Combined use of directional atherectomy and drug-coated balloon for the endovascular treatment of common femoral artery disease: immediate and one-year outcomes
STABILE, EUGENIO;IACOVELLI, FORTUNATO;TRIMARCO, BRUNO;ESPOSITO, GIOVANNI;
2017
Abstract
Surgical endarterectomy is the therapy of choice for atherosclerotic common femoral artery (CFA) obstruction. Recently, some large single-centre series have shown encouraging results for the percutaneous treatment of CFA obstructions. The purpose of this study was to evaluate the safety, feasibility, and one-year efficacy of the endovascular treatment of CFA obstructions with combined use of directional atherectomy (DA) and a paclitaxel-coated balloon (DCB).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
